http://topics.nytimes.com/top/news/business/companies/cerulean-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/forward-pharma-a-s/index.html
http://topics.nytimes.com/top/news/business/companies/aspenbio-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/china-pharma-holdings-inc/index.html
http://topics.nytimes.com/top/news/business/companies/cardiome-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/scolr-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nutra-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/kite-pharma-inc/index.html
http://dealbook.nytimes.com/2014/11/06/drug-maker-perrigo-to-acquire-omega-pharma/
http://topics.nytimes.com/top/news/business/companies/recro-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/targeted-medical-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/novadel-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/bio-blast-pharma-ltd/index.html
http://topics.nytimes.com/top/news/business/companies/zosano-pharma-corporation/index.html
http://www.nytimes.com/2014/11/11/opinion/big-pharma-and-ebola.html
http://www.nytimes.com/reuters/2014/10/20/business/20reuters-omega-actavis.html
http://www.nytimes.com/aponline/2014/11/06/business/ap-us-perrigo-omega-acquisition.html
http://www.nytimes.com/reuters/2014/10/29/technology/29reuters-google-pharmaceuticals-settlement.html
http://www.nytimes.com/aponline/2014/09/22/business/ap-us-auxilium-pharmaceuticals-endo-international.html
http://www.nytimes.com/aponline/2014/10/03/business/ap-us-salix-inversion-scuttled.html
http://www.nytimes.com/reuters/2014/10/24/business/24reuters-hikma-pharma-warning-fda.html
http://www.nytimes.com/reuters/2014/10/09/business/09reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/reuters/2014/10/15/business/15reuters-markets-stocks-europe.html
http://www.nytimes.com/aponline/2014/09/16/business/ap-us-endo-auxilium.html
http://www.nytimes.com/reuters/2014/09/21/sports/cycling/21reuters-cycling-world-ttt.html
http://www.nytimes.com/reuters/2014/09/18/business/18reuters-sinclair-results.html
http://www.nytimes.com/reuters/2014/09/23/business/23reuters-markets-stocks-ftse.html
http://www.nytimes.com/reuters/2014/09/16/business/16reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/reuters/2014/10/01/business/01reuters-flu-vaccine-analysis.html
http://topics.nytimes.com/top/news/business/companies/nexgen-biofuels-ltd/index.html
http://topics.nytimes.com/top/news/business/companies/blackstone-lake-minerals-inc/index.html
http://topics.nytimes.com/top/news/business/companies/marshall-edwards-inc/index.html
http://www.nytimes.com/2014/07/26/your-money/seeing-a-supersize-yacht-as-a-job-engine-not-a-self-indulgence.html
http://www.nytimes.com/2014/08/25/us/chicago-and-2-california-counties-sue-drug-companies-over-painkiller-marketing.html
http://www.nytimes.com/2014/07/24/business/fda-approves-pain-drug-meant-to-discourage-abuse.html
http://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html
http://www.nytimes.com/reuters/2014/08/06/business/06reuters-markets-britain-stocks.html
http://www.nytimes.com/reuters/2014/07/28/business/28reuters-reckitt-benc-grp-pharmaceuticals.html
http://www.nytimes.com/reuters/2014/10/20/business/20reuters-sigma-tau-m-a-alfa.html
http://www.nytimes.com/reuters/2014/07/12/business/12reuters-merck-deals.html
http://www.nytimes.com/reuters/2014/08/30/sports/cycling/30reuters-cycling-belgium-death.html
http://www.nytimes.com/reuters/2014/10/22/business/22reuters-kremersurban-m-a-adventavista.html
http://www.nytimes.com/reuters/2014/09/08/sports/cycling/08reuters-cycling-spain-fight.html
http://www.nytimes.com/2014/10/03/movies/the-culture-high-explores-marijuana-decriminalization.html
http://www.nytimes.com/aponline/2014/10/30/us/ap-us-nfl-drug-lawsuit.html
http://www.nytimes.com/reuters/2014/09/24/business/24reuters-markets-stocks-usa.html
http://www.nytimes.com/2014/08/31/sports/cycling/valverde-keeps-lead-at-vuelta-a-espaa.html
http://www.nytimes.com/reuters/2014/09/22/business/22reuters-merck-sigma-aldrich.html
http://www.nytimes.com/reuters/2014/11/03/business/03reuters-covance-m-a-laboratory-corp.html
http://www.nytimes.com/aponline/2014/06/20/business/ap-us-ipo-roundup-pricing.html
http://www.nytimes.com/reuters/2014/06/25/business/25reuters-markets-india-shares.html
http://www.nytimes.com/reuters/2014/09/02/sports/cycling/02reuters-cycling-spain.html
http://www.nytimes.com/reuters/2014/10/01/world/asia/01reuters-aids-india.html
http://www.nytimes.com/aponline/2014/10/15/us/politics/ap-us-supreme-court-generic-drug-dispute.html
http://www.nytimes.com/reuters/2014/10/15/us/politics/15reuters-usa-court-teva-arguments.html
http://www.nytimes.com/reuters/2014/08/22/sports/cycling/22reuters-cycling-britain-chavanel.html
http://www.nytimes.com/reuters/2014/11/13/world/asia/13reuters-india-health-sterilisation.html
http://www.nytimes.com/reuters/2014/10/07/world/africa/07reuters-health-ebola-pentagon.html
http://www.nytimes.com/reuters/2014/10/03/us/politics/03reuters-usa-court-business-cases-factbox.html
http://www.nytimes.com/aponline/2014/10/26/us/ap-us-ebola-pharma-opportunity.html
http://www.nytimes.com/reuters/2014/11/05/business/05reuters-health-ageing-drugmakers-analysis.html
http://www.nytimes.com/reuters/2014/09/07/sports/cycling/07reuters-cycling-britain.html
http://www.nytimes.com/reuters/2014/09/08/sports/cycling/08reuters-cycling-britain.html
http://www.nytimes.com/reuters/2014/09/04/business/04reuters-roche-m-a-chairman.html
http://www.nytimes.com/video/multimedia/100000003008328/abbvie-clinches-shire-deal.html
http://www.nytimes.com/2014/10/19/sunday-review/the-ebola-conspiracy-theories.html
http://www.nytimes.com/reuters/2014/09/23/world/africa/23reuters-health-ebola-trials.html
http://www.nytimes.com/reuters/2014/09/19/sports/cycling/19reuters-cycling-world.html
http://www.nytimes.com/reuters/2014/06/17/business/17reuters-gw-pharma.html
http://www.nytimes.com/2014/10/24/health/without-lucrative-market-potential-ebola-vaccine-was-shelved-for-years.html
http://www.nytimes.com/reuters/2014/09/15/business/15reuters-markets-stocks.html
http://www.nytimes.com/reuters/2014/09/03/sports/03reuters-cycling-spain.html
http://www.nytimes.com/reuters/2014/08/23/sports/cycling/23reuters-cycling-spain.html
http://www.nytimes.com/reuters/2014/08/12/business/12reuters-galenica.html
http://www.nytimes.com/reuters/2014/08/13/business/13reuters-astrazeneca-gout.html
http://www.nytimes.com/reuters/2014/06/12/business/12reuters-china-pharmaceuticals.html
http://www.nytimes.com/aponline/2014/08/30/us/ap-us-minnesota-senate-inversion.html
http://www.nytimes.com/aponline/2014/08/29/us/politics/ap-us-minnesota-senate-inversion.html
http://www.nytimes.com/video/multimedia/100000002998939/shire-ready-to-recommend-higher-abbvie-bid.html
http://www.nytimes.com/reuters/2014/09/04/sports/cycling/04reuters-cycling-britain-cavendish.html
http://www.nytimes.com/aponline/2014/09/16/us/politics/ap-us-prescription-painkillers-cities.html
http://www.nytimes.com/video/multimedia/100000002986933/asia-day-ahead-watch-out-for-the-ipo-effect.html
http://www.nytimes.com/reuters/2014/08/14/technology/14reuters-mobilephone-health.html
http://www.nytimes.com/2014/09/30/upshot/what-were-learning-about-drug-company-payments-to-doctors.html
http://www.nytimes.com/reuters/2014/09/12/business/12reuters-alibaba-group-ipo-performance-analysis.html
http://www.nytimes.com/2014/09/30/business/patents-put-overseas-can-pare-tax-bills.html
http://www.nytimes.com/reuters/2014/09/11/world/europe/11reuters-health-ebola-neglected-analysis.html
http://op-talk.blogs.nytimes.com/2014/10/02/do-you-have-time-to-read-this-story/
http://www.nytimes.com/reuters/2014/09/11/business/11reuters-alibaba-group-ipo-performance-analysis.html
http://dealbook.nytimes.com/2014/11/07/morning-agenda-bank-of-americas-legal-hit/
http://www.nytimes.com/aponline/2014/07/24/health/ap-eu-med-malaria-vaccine.html
http://www.nytimes.com/reuters/2014/08/10/sports/cycling/10reuters-cycling-london.html
http://www.nytimes.com/reuters/2014/06/01/business/01reuters-shire-m-a-nps.html
http://www.nytimes.com/reuters/2014/08/06/sports/cycling/06reuters-cycling-cavendish.html
http://www.nytimes.com/aponline/2014/08/06/business/ap-us-financial-markets-stocks.html
http://www.nytimes.com/reuters/2014/08/05/business/05reuters-kremersurban-sale.html
http://www.nytimes.com/reuters/2014/08/25/business/25reuters-intermune-roche.html
http://www.nytimes.com/reuters/2014/05/26/business/26reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/reuters/2014/08/24/business/24reuters-intermune-roche.html
http://dealbook.nytimes.com/2014/08/24/roche-to-buy-drug-maker-intermune-for-8-3-billion/
http://www.nytimes.com/reuters/2014/08/22/business/22reuters-volume-loans.html
http://www.nytimes.com/aponline/2014/07/24/health/ap-eu-med-contraceptives-review.html
http://www.nytimes.com/reuters/2014/05/24/business/24reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/reuters/2014/07/08/sports/cycling/08reuters-cycling-road-tour-de-france-results.html
http://www.nytimes.com/reuters/2014/08/15/business/15reuters-europe-stocks-funds-usa.html
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-road-tour-de-france-results.html
http://www.nytimes.com/reuters/2014/07/30/technology/30reuters-healthcare-tech.html
http://www.nytimes.com/reuters/2014/08/13/business/13reuters-mideast-gaza-israel-economy.html
http://www.nytimes.com/aponline/2014/07/23/business/ap-us-new-painkiller-fda.html
http://www.nytimes.com/reuters/2014/08/11/business/11reuters-sanofi-mannkind.html
http://dealbook.nytimes.com/2014/08/07/yellens-remarks-not-expected-to-dent-allure-of-biotech-companies/
http://www.nytimes.com/2014/07/20/fashion/weddings/lisa-baker-gus-steadman.html
http://www.nytimes.com/reuters/2014/07/28/business/28reuters-citigroup-asiapac-expansion.html
http://www.nytimes.com/reuters/2014/07/29/business/29reuters-citigroup-asiapac-expansion.html
http://www.nytimes.com/reuters/2014/08/06/us/06reuters-health-ebola-tobacco-feature.html
http://www.nytimes.com/reuters/2014/07/09/business/09reuters-credit-suisse-healthcare.html
http://www.nytimes.com/reuters/2014/05/22/business/22reuters-roche-hldg-china.html
http://www.legacy.com/Link.asp?I=LS000171790605
http://query.nytimes.com/gst/fullpage.html?res=9E03E7DE173AF933A15754C0A9629D8B63
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-tour-cavendish.html
http://www.nytimes.com/aponline/2014/05/13/business/ap-us-allergan-valeant.html
http://www.nytimes.com/reuters/2014/08/06/business/06reuters-walgreen-alliance-boots.html
http://www.nytimes.com/reuters/2014/05/12/business/12reuters-lumena-shire.html
http://www.nytimes.com/reuters/2014/07/14/business/14reuters-teva-pharm-ind-chairman.html
http://www.nytimes.com/2014/08/02/business/biotechnology-for-treating-dogs-and-cats.html
http://www.nytimes.com/reuters/2014/07/11/business/11reuters-privateequity-pharmaceuticals-portfolio.html
http://www.nytimes.com/reuters/2014/07/30/business/30reuters-usa-tax-ireland-analysis.html
http://www.nytimes.com/reuters/2014/07/22/business/22reuters-gsk-disposal.html
http://dealbook.nytimes.com/2014/07/30/valeants-cost-cutting-ethos-may-yet-give-wall-street-indigestion/
http://www.nytimes.com/2014/07/14/sports/cycling/french-rider-gains-yellow-jersey-on-eve-of-bastille-day.html
http://www.nytimes.com/reuters/2014/07/13/sports/cycling/13reuters-cycling-tour.html
http://dealbook.nytimes.com/2014/07/14/shire-and-abbvie-in-talks-over-53-billion-pharmaceutical-merger/
http://www.nytimes.com/reuters/2014/07/11/sports/cycling/11reuters-cycling-tour-winner.html
http://www.nytimes.com/aponline/2014/07/06/sports/ap-cyc-tour-de-france-cavendish-out.html
http://www.nytimes.com/reuters/2014/07/11/sports/cycling/11reuters-cycling-tour.html
http://www.nytimes.com/reuters/2014/07/05/sports/cycling/05reuters-cycling-tour-winner.html
http://www.nytimes.com/reuters/2014/07/05/sports/cycling/05reuters-cycling-tour-start.html
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-healthcare-m-a-factbox.html
http://www.nytimes.com/aponline/2014/07/24/us/ap-us-rick-perry-tech-fund.html
http://www.nytimes.com/reuters/2014/07/03/sports/cycling/03reuters-cycling-tour-cavendish.html
http://www.nytimes.com/reuters/2014/07/14/sports/cycling/14reuters-cycling-tour.html
http://www.nytimes.com/reuters/2014/07/08/sports/cycling/08reuters-cycling-tour.html
http://www.nytimes.com/reuters/2014/06/11/business/11reuters-novartis-japan.html
http://www.nytimes.com/reuters/2014/06/18/sports/cycling/18reuters-cycling-wiggins.html
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-tour.html
http://www.nytimes.com/2014/07/06/sports/cycling/german-wins-opening-tour-de-france-stage-in-england.html
http://www.nytimes.com/reuters/2014/04/30/business/30reuters-drug-britain-scientists.html
http://www.nytimes.com/reuters/2014/07/03/sports/cycling/03reuters-cycling-tour-froome.html
http://www.nytimes.com/reuters/2014/07/08/business/08reuters-shire-abbvie.html
http://www.nytimes.com/2014/06/24/sports/cycling/rui-costa-wins-3rd-straight-tour-de-suisse.html
http://www.nytimes.com/2014/06/24/sports/cycling/rui-costa-wins-3rd-straight-tour-de-suisse.html
http://www.nytimes.com/reuters/2014/07/08/world/europe/08reuters-health-alzheimers.html
http://www.nytimes.com/reuters/2014/07/07/world/europe/07reuters-health-alzheimers.html
http://www.nytimes.com/reuters/2014/05/04/business/04reuters-pharmaceuticals-sales.html
http://www.nytimes.com/reuters/2014/07/06/sports/cycling/06reuters-cycling-tour-cavendish.html
http://www.nytimes.com/reuters/2014/07/05/sports/cycling/05reuters-cycling-tour.html
http://www.nytimes.com/reuters/2014/06/20/business/20reuters-markets-britain-stocks.html
http://www.nytimes.com/reuters/2014/05/05/business/05reuters-ranbaxy-lab-sun-pharma-silverstreet.html
http://www.nytimes.com/reuters/2014/07/02/business/02reuters-health-antibiotics.html
http://www.nytimes.com/video/multimedia/100000002838976/big-pharma-braces-for-ma-wave.html
http://www.nytimes.com/aponline/2014/04/25/business/ap-us-prestige-brands-acquisition.html
http://www.nytimes.com/reuters/2014/04/29/business/29reuters-sanofi-earnings.html
http://www.nytimes.com/reuters/2014/07/06/world/europe/06reuters-health-antibiotics-insight.html
http://www.nytimes.com/reuters/2014/06/03/world/middleeast/03reuters-usa-drugs-lawsuit.html
http://www.nytimes.com/2014/07/20/business/international/tasmania-big-supplier-to-drug-companies-faces-changes.html
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-novartis.html
http://www.nytimes.com/reuters/2014/06/30/us/politics/30reuters-usa-court-contraceptives.html
http://www.nytimes.com/reuters/2014/06/24/business/24reuters-india-pharmaceuticals-exclusive.html
http://www.nytimes.com/aponline/2014/07/01/sports/ap-cyc-tour-de-france-riders-to-watch.html
http://www.nytimes.com/aponline/2014/06/03/us/ap-us-painkiller-makers-lawsuit-chicago.html
http://www.nytimes.com/reuters/2014/04/23/business/23reuters-novartis-gsk-assetswaps.html
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-usa-healthcare-mergers.html
http://www.nytimes.com/reuters/2014/06/25/business/25reuters-investment-hoarding.html
http://www.nytimes.com/reuters/2014/06/25/business/25reuters-investment-hoarding-analysis.html
http://dealbook.nytimes.com/2014/06/11/in-bid-for-botox-maker-valeant-defends-its-record-on-research/
http://www.nytimes.com/reuters/2014/05/27/sports/cycling/27reuters-cycling-holm.html
http://www.nytimes.com/video/multimedia/100000002858721/az-spurns-pfizer-bayermerck-deal-nears.html
http://www.nytimes.com/aponline/2014/05/31/us/ap-us-fda-interview-highlights.html
http://www.nytimes.com/aponline/2014/06/10/us/politics/ap-us-painkiller-abuse.html
http://www.nytimes.com/aponline/2014/04/10/business/ap-us-adamas-pharma-ipo.html
http://6thfloor.blogs.nytimes.com/2014/05/26/behind-the-cover-story-michael-behar-on-star-trek-acupuncture-and-bioelectronics/
http://www.nytimes.com/aponline/2014/05/30/us/politics/ap-us-fda-interview-highlights.html
http://op-talk.blogs.nytimes.com/2014/06/09/with-stay-lit-writers-persevere-in-a-hostile-world/
http://www.nytimes.com/reuters/2014/04/07/business/07reuters-daiichi-sankyo-ranbaxy-sunpharma-profit.html
http://www.nytimes.com/2014/05/24/opinion/studying-if-aspirin-helps-prevent-breast-cancer.html
http://www.nytimes.com/aponline/2014/04/07/business/ap-as-india-sun-pharma-ranbaxy.html
http://www.nytimes.com/reuters/2014/04/06/business/06reuters-daiichi-sankyo-ranbaxy-sunpharma.html
http://www.nytimes.com/2014/05/13/opinion/nocera-science-vs-taxes.html
http://dealbook.nytimes.com/2014/06/04/in-valeants-bid-for-allergan-an-opaque-business-model-is-revealed/
http://www.nytimes.com/reuters/2014/05/21/sports/cycling/21reuters-cycling-giro.html
http://www.nytimes.com/reuters/2014/04/09/business/09reuters-ranbaxy-sunpharma.html
http://www.nytimes.com/aponline/2014/05/22/us/ap-us-narcotics-makers-lawsuit.html
http://www.nytimes.com/2014/06/02/health/early-chemotherapy-extends-lives-of-men-with-prostate-cancer-study-finds.html
http://www.nytimes.com/aponline/2014/05/15/us/politics/ap-us-lunesta-fda-action.html
http://www.nytimes.com/reuters/2014/04/07/business/07reuters-daiichi-sankyo-ranbaxy-sunpharma.html
http://www.nytimes.com/reuters/2014/05/19/business/19reuters-markets-stocks.html
http://www.nytimes.com/reuters/2014/05/14/business/14reuters-astrazeneca-pfizer-jj.html
http://www.nytimes.com/reuters/2014/05/14/business/14reuters-astrazeneca-pfizer-j-j.html
http://www.nytimes.com/reuters/2014/05/28/us/28reuters-usa-healthcare-hepatitisc-insight.html
http://www.nytimes.com/2014/05/17/nyregion/robbery-suspect-tracked-by-gps-and-killed.html
http://www.nytimes.com/aponline/2014/05/09/us/ap-us-imported-drugs.html
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-astrazeneca-pfizer-epanova.html
http://www.nytimes.com/roomfordebate/2014/05/13/pets-and-medication/
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-novartis-boltons.html
http://www.nytimes.com/reuters/2014/05/01/business/01reuters-shire.html
http://www.nytimes.com/reuters/2014/05/11/business/11reuters-astrazeneca-pfizer-global.html
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-markets-britain-stocks.html
http://www.nytimes.com/2014/03/13/business/abuse-resistant-hydrocodone-could-sink-sales-of-new-drug.html
http://www.nytimes.com/video/multimedia/100000002810736/cautionary-tale-for-japan-ma-in-ranbaxy-fail.html
http://dealbook.nytimes.com/2014/04/28/forest-labs-to-acquire-furiex-pharmaceuticals/
http://www.nytimes.com/reuters/2014/03/19/business/19reuters-horizonpharma-acquisition.html
http://www.nytimes.com/aponline/2014/04/28/business/ap-us-forest-labs-furiex-acquisition.html
http://www.nytimes.com/2014/05/03/opinion/end-corporate-taxation.html
http://www.nytimes.com/reuters/2014/04/25/business/25reuters-investment-banking-activity-survey.html
http://www.nytimes.com/reuters/2014/05/01/world/asia/01reuters-india-usa-trade.html
http://dealbook.nytimes.com/2014/04/06/sun-pharmaceuticals-of-india-to-buy-ranbaxy-a-smaller-rival/
http://www.nytimes.com/aponline/2014/04/21/us/ap-us-allergan-valeant.html
http://www.nytimes.com/reuters/2014/03/13/business/13reuters-sun-pharma-india-fda.html
http://www.nytimes.com/reuters/2014/04/18/world/europe/18reuters-usa-court-teva-pharm-ind.html
http://www.nytimes.com/reuters/2014/04/24/business/24reuters-novartis-results.html
http://www.nytimes.com/reuters/2014/03/12/business/12reuters-bayer-outlook.html
http://www.nytimes.com/reuters/2014/04/30/business/30reuters-publicis-groupe-omnicom-group-clients-insight.html
http://www.nytimes.com/reuters/2014/05/01/business/01reuters-publicis-groupe-omnicom-group-clients-insight.html
http://dealbook.nytimes.com/2014/04/07/drug-sale-shows-risk-in-japans-m-a-adventures/
http://www.nytimes.com/reuters/2014/04/09/business/09reuters-ranbaxy-lab-regulator.html
http://www.nytimes.com/reuters/2014/04/15/business/15reuters-roche-hldg-results.html
http://www.nytimes.com/reuters/2014/04/12/sports/cycling/12reuters-cycling-basque.html
http://www.nytimes.com/reuters/2014/04/13/sports/cycling/13reuters-cycling-roubaix.html
http://www.nytimes.com/2014/04/25/theater/the-great-immensity-gives-environmentalism-its-own-lyrics.html
http://www.nytimes.com/reuters/2014/04/07/world/europe/07reuters-usa-court-ip.html
http://www.nytimes.com/reuters/2014/04/10/business/10reuters-markets-stocks.html
http://www.nytimes.com/reuters/2014/04/04/business/04reuters-meda-mylan.html
http://www.nytimes.com/aponline/2014/04/04/business/ap-grubhub-ipo-glance.html
http://dealbook.nytimes.com/2014/03/27/conscious-uncoupling-for-drug-makers/
http://www.nytimes.com/reuters/2014/04/02/business/02reuters-sanofi-ceo.html
http://www.nytimes.com/reuters/2014/03/25/business/25reuters-markets-stocks.html
http://www.nytimes.com/aponline/2014/02/11/business/ap-us-mallinckrodt-acquisition.html
http://dealbook.nytimes.com/2014/04/07/morning-agenda-credit-suisses-growing-headache/
http://www.nytimes.com/2014/04/01/business/supreme-court-to-hear-appeal-of-multiple-sclerosis-drug-case.html
http://www.nytimes.com/aponline/2014/03/27/business/ap-us-baxter-split.html
http://www.nytimes.com/reuters/2014/02/12/business/12reuters-reckittbenckiser-results.html
http://www.nytimes.com/aponline/2014/02/07/us/politics/ap-us-sports-doping-drugmakers.html
http://www.nytimes.com/2014/03/14/movies/better-living-through-chemistry-or-at-least-better-loving.html
http://dealbook.nytimes.com/2014/03/20/morning-agenda-questioning-the-leverage-ratio/
http://www.nytimes.com/reuters/2014/03/02/business/02reuters-novartis-chairman.html
http://www.nytimes.com/aponline/2014/03/03/us/ap-us-forbes-billionaires-glance.html
http://www.nytimes.com/2014/03/18/education/a-degree-where-techie-meets-business-smarts.html
http://www.nytimes.com/reuters/2014/03/13/us/13reuters-zogenix-zohydro-fda.html
http://www.nytimes.com/reuters/2014/02/02/business/02reuters-novartis-jobs.html
http://www.nytimes.com/reuters/2014/03/10/business/10reuters-markets-stocks.html
http://www.nytimes.com/2014/01/29/health/drug-shows-promise-in-advanced-prostate-cancer-when-used-before-chemotherapy.html
http://www.nytimes.com/reuters/2014/03/03/business/03reuters-swiss-drugmakers-chairmen.html
http://www.nytimes.com/reuters/2014/02/18/business/18reuters-germany-drugs-analysis.html
http://dealbook.nytimes.com/2014/02/24/cinven-to-buy-clinical-research-firm/
http://www.nytimes.com/reuters/2014/03/11/us/politics/11reuters-usa-court-contraception-analysis.html
http://www.nytimes.com/reuters/2014/03/04/business/04reuters-roche-chairman.html
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-novartis-tokyo-raid.html
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-tokyo-prosecutors-raid-novartis-japan-unit-i.html
http://boss.blogs.nytimes.com/2014/02/26/today-in-small-business-online-reviews-matter-more-than-most-owners-think/
http://www.nytimes.com/2014/02/28/opinion/krugman-no-big-deal.html
http://www.nytimes.com/2014/03/02/books/review/the-meat-racket-and-in-meat-we-trust.html
http://boss.blogs.nytimes.com/2014/02/27/how-a-content-company-reinvented-itself-as-a-technology-company/
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-novartis-japan-raid.html
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-tokyo-novartis.html
http://www.nytimes.com/reuters/2014/01/17/world/17reuters-safrica-pharma.html
http://www.nytimes.com/reuters/2014/02/18/business/18reuters-actavis-forestlabs.html
http://www.nytimes.com/aponline/2014/02/18/us/ap-us-actavis-forest-labs.html
http://www.nytimes.com/aponline/2014/02/05/sports/ap-cyc-dubai-tour.html
http://dealbook.nytimes.com/2014/01/08/forest-labs-to-buy-specialty-drug-maker-for-2-9-billion/
http://www.nytimes.com/reuters/2014/02/10/business/10reuters-markets-stocks.html
http://www.nytimes.com/2014/02/10/world/europe/exposing-a-corporate-trend-in-higher-education-in-germany.html
http://www.nytimes.com/reuters/2014/02/09/business/09reuters-safrica-currency.html
http://www.nytimes.com/reuters/2014/02/03/business/03reuters-ablynx-merck.html
http://www.nytimes.com/aponline/2014/01/24/health/ap-eu-med-contraceptive-pill-review.html
http://www.nytimes.com/reuters/2014/01/26/business/26reuters-pharmaceutical-deals-analysis.html
http://dealbook.nytimes.com/2014/02/07/morning-agenda-a-guilty-verdict-for-former-sac-trader/
http://www.nytimes.com/aponline/2014/01/09/world/asia/ap-as-japan-novartis.html
http://www.nytimes.com/reuters/2014/01/08/business/08reuters-novartis-diovan-japan.html
http://www.nytimes.com/reuters/2014/01/20/business/20reuters-usa-stocks-shorts-insight.html
http://www.nytimes.com/reuters/2013/12/19/business/19reuters-markets-britain-stocks.html
http://www.nytimes.com/2014/01/15/realestate/commercial/joel-s-marcus.html
http://www.nytimes.com/reuters/2013/12/15/business/15reuters-markets-india-shares.html
http://www.nytimes.com/reuters/2014/01/07/business/07reuters-forest-aptalis.html
http://www.nytimes.com/reuters/2014/01/13/business/13reuters-china-ipos.html
http://www.nytimes.com/reuters/2014/01/07/business/07reuters-novartis-roche-lungdrugs.html
http://dealbook.nytimes.com/2013/12/31/the-risks-of-investing-in-animal-medicine/
http://www.nytimes.com/2014/01/05/opinion/sunday/sunday-dialogue-treating-mental-illness.html
http://www.nytimes.com/reuters/2013/12/30/business/30reuters-china-ipo.html
http://krugman.blogs.nytimes.com/2013/12/14/tpp-and-ip-a-brief-note/
http://www.nytimes.com/roomfordebate/2014/01/01/thinking-beyond-the-birth-control-pill/
http://www.nytimes.com/2013/12/19/opinion/the-rise-in-diagnoses-of-adhd.html
http://dealbook.nytimes.com/2013/12/20/jazz-deal-for-gentium-shows-benefits-of-inversions/
http://www.nytimes.com/reuters/2013/12/19/business/19reuters-algeta-bayer.html
http://www.nytimes.com/reuters/2013/12/24/world/middleeast/24reuters-setad-ipo-exclusive.html
http://www.nytimes.com/reuters/2013/12/08/business/08reuters-novartis.html
http://www.nytimes.com/reuters/2013/12/24/world/middleeast/24reuters-setad-ipo.html
http://www.nytimes.com/aponline/2013/12/11/us/politics/ap-us-generic-cymbalta.html
http://www.nytimes.com/aponline/2013/12/17/world/europe/ap-eu-britain-gsk.html
http://www.nytimes.com/2013/11/15/business/chicago-reviews-marketing-by-makers-of-narcotic-painkillers.html
http://dealbook.nytimes.com/2013/12/17/despite-doldrums-in-deal-activity-a-few-highlights-this-year/
http://www.nytimes.com/reuters/2013/12/17/business/17reuters-glaxosmithkline-payment.html
http://www.nytimes.com/2013/12/18/opinion/bittman-the-fdas-not-really-such-good-news.html
http://www.nytimes.com/aponline/2013/12/11/business/ap-us-business-highlights.html
http://www.nytimes.com/2013/12/15/health/the-selling-of-attention-deficit-disorder.html
http://www.nytimes.com/aponline/2013/12/07/health/ap-us-med-gene-therapy-cancer.html
http://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html
http://dealbook.nytimes.com/2013/11/19/dutch-firm-to-spin-off-drug-making-business-in-2-6-billion-deal/
http://www.nytimes.com/2013/11/24/business/selling-that-new-man-feeling.html
http://well.blogs.nytimes.com/2013/11/11/doctors-boundaries-with-patients/
http://www.nytimes.com/2013/11/17/health/in-demand-in-clinics-and-on-the-street-bupe-can-be-savior-or-menace.html
http://www.nytimes.com/2013/11/18/health/at-clinics-tumultuous-lives-and-turbulent-care.html
http://www.nytimes.com/2013/10/29/business/generic-rivals-sharply-erode-mercks-results.html
http://www.nytimes.com/2013/10/23/realestate/commercial/recent-commercial-real-estate.html
http://www.nytimes.com/2013/10/16/opinion/the-high-cost-of-asthma-in-america.html
http://www.nytimes.com/aponline/2013/09/19/business/ap-us-acceleron-pharma-ipo-mover.html
http://www.nytimes.com/reuters/2013/09/18/business/18reuters-china-pharma-sales-analysis.html
http://www.nytimes.com/reuters/2013/09/12/business/12reuters-india-drugs-analysis.html
http://india.blogs.nytimes.com/2013/10/08/an-indians-maiden-visit-to-pakistan/
http://www.nytimes.com/2013/10/06/opinion/sunday/sunday-dialogue-a-disillusioned-citizenry.html
http://www.nytimes.com/2013/09/30/opinion/psychotherapys-image-problem.html
http://www.legacy.com/Link.asp?I=LS000167034421
http://www.nytimes.com/reuters/2013/09/05/business/05reuters-china-bribery-probe.html
http://query.nytimes.com/gst/fullpage.html?res=9903E0DB123AF93AA2575AC0A9659D8B63
http://www.nytimes.com/reuters/2013/09/21/sports/cycling/21reuters-cycling-britain.html
http://www.nytimes.com/reuters/2013/09/22/sports/cycling/22reuters-cycling-world-teamtrial.html
http://www.nytimes.com/aponline/2013/09/24/us/ap-us-stem-cell-scam-vegas.html
http://www.nytimes.com/aponline/2013/09/20/business/ap-us-ipo-preview.html
http://opinionator.blogs.nytimes.com/2013/09/21/american-bile/
http://www.nytimes.com/reuters/2013/09/12/world/europe/12reuters-sanofi.html
http://www.nytimes.com/reuters/2013/09/11/business/11reuters-roche-interview.html
http://www.nytimes.com/reuters/2013/09/12/business/12reuters-eu-telecoms.html
http://www.nytimes.com/reuters/2013/09/06/sports/cycling/06reuters-cycling-britain-cavendish.html
http://www.nytimes.com/reuters/2013/08/30/sports/cycling/30reuters-cycling-spain-winner.html
http://www.nytimes.com/reuters/2013/08/24/sports/cycling/24reuters-cycling-vuelta-winner.html
http://www.nytimes.com/reuters/2013/08/30/sports/cycling/30reuters-cycling-spain.html
http://www.nytimes.com/reuters/2013/08/22/sports/cycling/22reuters-cycling-boonen.html
http://www.nytimes.com/reuters/2013/08/24/sports/cycling/24reuters-cycling-vuelta.html
http://www.nytimes.com/reuters/2013/08/02/business/02reuters-india-gsk.html
http://www.nytimes.com/reuters/2013/08/01/sports/cycling/01reuters-cycling-omegapharma-uran.html
http://www.nytimes.com/reuters/2013/08/21/business/21reuters-onyx-deal.html
http://www.nytimes.com/reuters/2013/07/29/business/29reuters-valeant-jobs.html
http://www.nytimes.com/reuters/2013/08/14/business/14reuters-novartis-review.html
http://www.nytimes.com/reuters/2013/08/07/business/07reuters-aptalis-tpg.html
http://www.nytimes.com/reuters/2013/07/23/us/23reuters-gsk-china.html
http://www.legacy.com/Link.asp?I=LS000166265017
http://query.nytimes.com/gst/fullpage.html?res=9407EFDD143AF936A3575BC0A9659D8B63
http://www.nytimes.com/aponline/2013/07/18/business/ap-us-oncomed-pharma-ipo-pricing.html
http://www.nytimes.com/reuters/2013/08/08/business/08reuters-novonordisk-result.html
http://dealbook.nytimes.com/2013/07/29/perrigo-to-buy-irish-drug-maker-for-6-7-billion/
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour.html
http://www.nytimes.com/aponline/2013/08/04/us/ap-us-cancer-funding-texas.html
http://www.nytimes.com/reuters/2013/07/29/business/29reuters-elan.html
http://www.nytimes.com/reuters/2013/07/22/business/22reuters-markets-britain-stocks.html
http://www.nytimes.com/reuters/2013/07/30/business/30reuters-pharmaceuticals-results.html
http://www.nytimes.com/reuters/2013/07/29/business/29reuters-bayer-breakup-analysis.html
http://www.nytimes.com/aponline/2013/07/29/business/ap-eu-ireland-elan-perrigo.html
http://www.nytimes.com/reuters/2013/07/24/business/24reuters-elan-bids.html
http://www.nytimes.com/reuters/2013/07/03/business/03reuters-alliancepharma-interview.html
http://www.nytimes.com/reuters/2013/07/19/business/19reuters-gsk-china-ucb.html
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour-winner.html
http://www.nytimes.com/reuters/2013/07/18/business/18reuters-gsk-china-ucb.html
http://www.nytimes.com/2013/07/22/sports/cycling/froome-gives-britain-a-second-straight-tour-de-france-victory.html
http://www.nytimes.com/reuters/2013/07/17/business/17reuters-gsk-china-compliance.html
http://www.nytimes.com/reuters/2013/07/12/business/12reuters-elan-bids.html
http://www.nytimes.com/2013/07/21/sports/cycling/froome-is-one-stage-away-from-tour-victory.html
http://www.nytimes.com/aponline/2013/06/27/business/ap-us-fda-online-pharmacies-summary-box.html
http://www.nytimes.com/2013/07/19/sports/cycling/riblon-wins-stage-of-dual-ascents-froome-holds-lead.html
http://www.nytimes.com/reuters/2013/07/17/business/17reuters-china-multinationals-crackdown.html
http://www.nytimes.com/2013/07/14/sports/cycling/toiling-in-anonymity-lead-out-riders-blaze-the-paths-for-sprinters.html
http://www.nytimes.com/reuters/2013/07/10/sports/cycling/10reuters-cycling-tour-cavendish.html
http://www.nytimes.com/reuters/2013/07/11/sports/cycling/11reuters-cycling-tour.html
http://www.nytimes.com/reuters/2013/07/11/sports/cycling/11reuters-cyycling-tour-winner.html
http://www.nytimes.com/2013/07/17/sports/cycling/17iht-tour17.html
http://www.nytimes.com/2013/07/15/sports/cycling/15iht-tour15.html
http://www.nytimes.com/2013/07/17/sports/cycling/what-goes-up-at-the-tour-descends-dangerously-fast.html
http://www.nytimes.com/reuters/2013/07/12/sports/cycling/12reuters-cycling-tour-sky.html
http://www.nytimes.com/reuters/2013/07/12/sports/cycling/12reuters-cycling-tour.html
http://www.nytimes.com/2013/07/13/sports/cycling/13iht-tour13.html
http://www.nytimes.com/2013/07/16/sports/cycling/english-is-the-force-majeure-in-a-changing-language-landscape-at-the-tour.html
http://www.nytimes.com/2013/07/16/sports/cycling/16iht-cycling16.html
http://dealbook.nytimes.com/2013/07/11/biotech-companies-surge-as-investors-flock-to-them/
http://www.nytimes.com/2013/07/17/booming/answers-about-rheumatoid-arthritis-part-1.html
http://www.nytimes.com/aponline/2013/07/12/sports/ap-cyc-tour-de-france.html
http://www.nytimes.com/aponline/2013/07/09/sports/ap-cyc-tour-de-france-5-things-to-know.html
http://www.nytimes.com/reuters/2013/07/09/sports/cycling/09reuters-cycling-tour.html
http://www.nytimes.com/aponline/2013/06/19/world/europe/ap-eu-eu-generic-medicine.html
http://dealbook.nytimes.com/2013/06/17/battle-for-elan-in-doubt-after-shareholders-approve-buyback-plan/
http://dealbook.nytimes.com/2013/06/18/royalty-pharma-drops-bid-for-elan/
http://www.nytimes.com/reuters/2013/07/12/business/12reuters-gsk-china-emergingmarkets-analysis.html
http://www.nytimes.com/aponline/2013/06/18/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/aponline/2013/07/10/sports/ap-cyc-tour-de-france.html
http://opinionator.blogs.nytimes.com/2013/07/09/breeding-bacteria-on-factory-farms/
http://www.nytimes.com/aponline/2013/07/07/sports/ap-cyc-tour-de-france-5-things-to-know.html
http://dealbook.nytimes.com/2013/06/14/elan-puts-itself-up-for-sale/
http://www.nytimes.com/reuters/2013/07/02/sports/cycling/02reuters-cycling-tour.html
http://www.nytimes.com/reuters/2013/07/02/sports/cycling/02reuters-cycling-tour-winner.html
http://www.nytimes.com/reuters/2013/07/03/sports/cycling/03reuters-cycling-tour.html
http://www.nytimes.com/reuters/2013/07/03/sports/cycling/03reuters-cycling-tour-winner.html
http://www.nytimes.com/reuters/2013/07/04/sports/cycling/04reuters-cycling-tour.html
http://www.nytimes.com/2013/07/03/sports/cycling/03iht-cycle03.html
http://www.nytimes.com/aponline/2013/07/03/sports/ap-cyc-tour-de-france-5-things-to-know.html
http://www.nytimes.com/reuters/2013/06/14/business/14reuters-royaltpharma-response.html
http://www.nytimes.com/aponline/2013/07/02/sports/ap-cyc-tour-de-france.html
http://www.nytimes.com/reuters/2013/07/02/sports/cycling/02reuters-cycling-tour-millar.html
http://www.nytimes.com/2013/07/05/sports/cycling/05iht-tour05.html
http://www.nytimes.com/aponline/2013/07/03/sports/ap-cyc-tour-de-france.html
http://www.nytimes.com/2013/07/05/sports/cycling/german-sprints-to-victory-in-stage-6.html
http://www.nytimes.com/2013/07/03/sports/cycling/team-effort-redeems-orica-greenedge-in-tour-de-france.html
http://www.nytimes.com/reuters/2013/07/01/business/01reuters-insidertrading-appeal.html
http://www.nytimes.com/reuters/2013/07/01/sports/cycling/01reuters-cycling-tour-timetrial.html
http://www.nytimes.com/2013/06/30/sports/cycling/german-rider-wins-tour-de-frances-chaotic-first-stage.html
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-dealtalk-drugmakers-ireland.html
http://www.nytimes.com/reuters/2013/06/29/sports/cycling/29reuters-cycling-tour-bus.html
http://opinionator.blogs.nytimes.com/2013/06/30/the-orphan-jackpot/
http://www.nytimes.com/reuters/2013/06/12/business/12reuters-pfizer-patent.html
http://dealbook.nytimes.com/2013/06/07/royalty-pharma-raises-its-bid-for-elan-again/
http://www.nytimes.com/reuters/2013/06/09/business/09reuters-elan-royalty.html
http://dealbook.nytimes.com/2013/06/06/elan-finds-creative-poison-pill-to-defend-against-a-hostile-bid/
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-elan-royalty-pharma-summary-box.html
http://www.nytimes.com/2013/06/28/sports/cycling/riders-to-watch-at-the-tour-de-france.html
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/reuters/2013/06/07/business/07reuters-royalty-elan.html
http://www.nytimes.com/reuters/2013/06/19/business/19reuters-forest-elan.html
http://www.nytimes.com/aponline/2013/06/25/business/ap-us-earns-walgreen.html
http://www.nytimes.com/reuters/2013/06/21/business/21reuters-vivus-proxy.html
http://www.nytimes.com/2013/06/28/sports/cycling/tour-de-france-chris-froome-alberto-contador.html
http://www.nytimes.com/reuters/2013/06/26/business/26reuters-funds-ageing.html
http://www.nytimes.com/reuters/2013/06/18/business/18reuters-astellas-sale.html
http://www.nytimes.com/aponline/2013/06/17/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/reuters/2013/06/18/business/18reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-elan-sharebuyback.html
http://www.nytimes.com/reuters/2013/06/11/business/11reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/05/31/business/31reuters-meda-sunpharma.html
http://www.nytimes.com/aponline/2013/06/14/business/ap-us-wall-street-stocks.html
http://www.nytimes.com/aponline/2013/05/28/business/ap-us-astrazeneca-acquisition.html
http://www.nytimes.com/reuters/2013/06/14/business/14reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-elan-royalty-court.html
http://www.nytimes.com/reuters/2013/06/13/business/13reuters-elan-royalty.html
http://www.nytimes.com/aponline/2013/06/14/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/reuters/2013/06/12/business/12reuters-elan-royalty-appeal.html
http://dealbook.nytimes.com/2013/06/19/dish-backs-away-from-sprint/
http://dealbook.nytimes.com/2013/06/17/telefonica-shares-climb/
http://www.nytimes.com/aponline/2013/06/10/business/ap-us-elan-royalty-pharma.html
http://dealbook.nytimes.com/2013/06/18/fraud-charges-for-former-ubs-trader/
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-elan-royalty.html
http://dealbook.nytimes.com/2013/05/20/royalty-pharma-raises-bid-for-a-resistant-elan/
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-wall-street-stocks.html
http://www.nytimes.com/reuters/2013/06/13/business/13reuters-elan-royalty-martin.html
http://www.nytimes.com/aponline/2013/06/11/business/ap-us-altria-group-electronic-cigarette.html
http://www.nytimes.com/reuters/2013/06/03/business/03reuters-elan-royalty-merger.html
http://www.nytimes.com/reuters/2013/06/04/business/04reuters-elan-royalty.html
http://www.nytimes.com/aponline/2013/06/04/business/ap-us-elan-royalty-pharma-restraining-order.html
http://www.nytimes.com/aponline/2013/05/20/business/ap-us-elan-royalty-pharma-offer.html
http://www.nytimes.com/2013/06/09/nyregion/less-than-a-fair-share-of-bike-share.html
http://dealbook.nytimes.com/2013/06/10/weighing-alternatives-to-a-telecom-deal/
http://www.nytimes.com/reuters/2013/06/07/business/07reuters-forest-icahn.html
http://www.nytimes.com/2013/06/09/magazine/the-5-26-13-issue.html
http://www.nytimes.com/reuters/2013/06/06/technology/06reuters-israel-biomed.html
http://www.nytimes.com/reuters/2013/05/30/business/30reuters-elan.html
http://www.nytimes.com/reuters/2013/05/29/business/29reuters-amgen-astellas.html
http://www.nytimes.com/reuters/2013/05/28/business/28reuters-astrazeneca-omthera.html
http://www.nytimes.com/reuters/2013/05/29/world/europe/29reuters-usa-smithfield-ractopamine-analysis.html
http://www.nytimes.com/2013/05/26/books/review/the-rule-of-the-clan-by-mark-weiner-and-more.html
http://www.nytimes.com/reuters/2013/05/23/business/23reuters-elan-royalty.html
http://krugman.blogs.nytimes.com/2013/05/17/that-hideous-strength/
http://dealbook.nytimes.com/2013/05/13/elan-in-deal-on-drug-royalties/
http://dealbook.nytimes.com/2013/05/21/yahoos-gamble/
http://www.nytimes.com/reuters/2013/05/16/sports/cycling/16reuters-cycling-giro.html
http://www.nytimes.com/reuters/2013/05/17/sports/cycling/17reuters-cycling-giro.html
http://www.nytimes.com/reuters/2013/05/09/sports/cycling/09reuters-cycling-giro-winner.html
http://dealbook.nytimes.com/2013/05/17/elliott-and-hess-shake-hands/
http://www.nytimes.com/reuters/2013/05/13/business/13reuters-elan-theravance.html
http://www.nytimes.com/aponline/2013/05/13/business/ap-us-elan-theravance-royalty-agreement.html
http://www.nytimes.com/2013/05/11/business/endo-loses-bid-to-block-sales-of-generic-painkiller.html
http://www.nytimes.com/reuters/2013/05/12/sports/cycling/12reuters-cycling-giro-monday.html
http://www.nytimes.com/2013/05/19/magazine/say-hello-to-the-100-trillion-bacteria-that-make-up-your-microbiome.html
http://query.nytimes.com/gst/fullpage.html?res=9C02E2DD1E39F936A35756C0A9659D8B63
http://www.nytimes.com/2013/05/05/sports/cycling/mark-cavendish-leads-in-giro-ditalia.html
http://www.nytimes.com/reuters/2013/05/09/sports/cycling/09reuters-cycling-giro.html
http://www.nytimes.com/aponline/2013/04/22/business/ap-eu-ireland-elan.html
http://www.nytimes.com/reuters/2013/05/10/business/10reuters-usa-health-drugs-analysis.html
http://www.nytimes.com/2013/04/20/opinion/the-loss-of-generic-oxycontin.html
http://www.nytimes.com/2013/04/17/business/fda-bars-generic-oxycontin.html
http://www.nytimes.com/reuters/2013/05/04/sports/cycling/04reuters-cycling-giro.html
http://www.nytimes.com/aponline/2013/05/04/sports/ap-cyc-giro.html
http://www.nytimes.com/aponline/2013/04/15/business/ap-us-royalty-pharma-elan-offer.html
http://www.nytimes.com/2013/05/05/books/review/a-delicate-truth-by-john-le-carre.html
http://www.nytimes.com/aponline/2013/05/02/sports/ap-cyc-giro-preview.html
http://www.nytimes.com/reuters/2013/04/11/business/11reuters-royaltypharma-elan.html
http://www.nytimes.com/reuters/2013/04/22/business/22reuters-informa-results.html
http://www.nytimes.com/reuters/2013/04/22/business/22reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/04/24/technology/24reuters-thermofisher-results.html
http://www.nytimes.com/reuters/2013/04/25/business/25reuters-astrazeneca-results.html
http://www.nytimes.com/reuters/2013/04/25/business/25reuters-markets-stocks.html
http://www.nytimes.com/aponline/2013/04/16/us/politics/ap-us-oxycontin-generic-versions.html
http://www.nytimes.com/reuters/2013/04/02/business/02reuters-india-pharmaceuticals.html
http://dealbook.nytimes.com/2013/04/22/schwarzmans-scholarship-in-china/
http://www.nytimes.com/reuters/2013/04/18/business/18reuters-elan.html
http://www.nytimes.com/reuters/2013/04/15/business/15reuters-royaltypharma-elan.html
http://www.nytimes.com/reuters/2013/04/19/business/19reuters-anaemia-pill.html
http://www.nytimes.com/2013/04/17/business/fda-rejects-levadex-a-new-drug-for-migraines.html
http://www.nytimes.com/reuters/2013/04/15/business/15reuters-merger-monday.html
http://krugman.blogs.nytimes.com/2013/04/13/dnwr-in-the-ea/
http://www.nytimes.com/reuters/2013/04/12/business/12reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/03/27/business/27reuters-india-drugs-glivec.html
http://www.nytimes.com/reuters/2013/04/11/business/11reuters-roche-results.html
http://www.nytimes.com/reuters/2013/04/11/world/europe/11reuters-neuroscience.html
http://www.nytimes.com/aponline/2013/04/08/business/ap-us-wall-street-stocks.html
http://www.nytimes.com/reuters/2013/04/08/sports/cycling/08reuters-cycling-sky.html
http://www.nytimes.com/reuters/2013/04/06/sports/cycling/06reuters-cycling-spain.html
http://www.nytimes.com/reuters/2013/04/06/sports/cycling/06reuters-cycling-spain-winner.html
http://www.nytimes.com/aponline/2013/03/21/business/ap-us-enanta-pharmaceuticals-ipo.html
http://www.nytimes.com/2013/04/04/business/media/an-ms-drug-takes-a-feisty-approach-aimed-at-younger-patients.html
http://query.nytimes.com/gst/fullpage.html?res=9A0CEED81F3CF93AA35757C0A9659D8B63
http://www.nytimes.com/reuters/2013/04/03/business/03reuters-astrazeneca.html
http://well.blogs.nytimes.com/2013/04/08/thinking-twice-about-calcium-supplements-2/
http://www.nytimes.com/reuters/2013/04/02/business/02reuters-elan.html
http://www.nytimes.com/2013/04/07/business/mutfund/health-care-mutual-funds-with-new-faces-at-the-helm.html
http://www.nytimes.com/reuters/2013/03/31/sports/cycling/31reuters-cycling-flanders.html
http://www.nytimes.com/reuters/2013/04/01/business/01reuters-india-novartis-patent.html
http://www.nytimes.com/2013/04/03/opinion/diagnosis-human.html
http://www.nytimes.com/2013/03/30/business/invokana-wins-fda-approval-for-diabetes-treatment.html
http://www.nytimes.com/aponline/2013/03/31/world/asia/ap-as-india-patent-battle.html
http://www.nytimes.com/aponline/2013/03/25/us/ap-10-things-to-know-today.html
http://www.nytimes.com/reuters/2013/03/06/business/06reuters-royaltypharma-elan.html
http://www.nytimes.com/reuters/2013/03/25/business/25reuters-roche-biosimilars.html
http://www.nytimes.com/reuters/2013/03/04/business/04reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/03/22/us/22reuters-jj-botox.html
http://www.nytimes.com/2013/03/24/opinion/sunday/sunday-dialogue-defining-mental-illness.html
http://www.nytimes.com/reuters/2013/03/18/world/asia/18reuters-usa-court-generics.html
http://www.nytimes.com/reuters/2013/03/17/sports/cycling/17reuters-cycling-sanremo.html
http://krugman.blogs.nytimes.com/2013/03/12/the-eurobeatings-will-continue/
http://www.nytimes.com/reuters/2013/03/18/business/18reuters-astrazeneca-rd.html
http://www.nytimes.com/reuters/2013/03/18/business/18reuters-astrazeneca-strategy.html
http://www.nytimes.com/2013/03/19/business/use-of-generics-produces-an-unusual-drop-in-drug-spending.html
http://dealbook.nytimes.com/2013/02/25/buyout-offer-will-likely-not-end-elans-merger-ambitions/
http://www.nytimes.com/aponline/2013/02/25/business/ap-us-royalty-pharma-elan.html
http://www.nytimes.com/reuters/2013/03/14/business/14reuters-cinven-fund.html
http://www.nytimes.com/reuters/2013/02/26/business/26reuters-royaltypharma-endo.html
http://dealbook.nytimes.com/2013/02/25/royalty-pharma-proposes-to-buy-elan-for-6-6-billion/
http://www.nytimes.com/aponline/2013/03/04/business/ap-us-elan-tysabri-dividend.html
http://www.nytimes.com/reuters/2013/03/04/business/04reuters-theravance-shares.html
http://www.nytimes.com/aponline/2013/03/05/world/asia/ap-as-india-generic-drug.html
http://www.nytimes.com/reuters/2013/03/04/business/04reuters-elan.html
http://www.legacy.com/Link.asp?I=LS000163321031
http://www.nytimes.com/reuters/2013/02/26/business/26reuters-nestle.html
http://www.nytimes.com/reuters/2013/02/11/business/11reuters-perrigo-acquisition.html
http://www.nytimes.com/aponline/2013/02/25/business/ap-us-business-highlights-.html
http://dealbook.nytimes.com/2013/02/25/top-deal-maker-returns-to-the-law/
http://www.nytimes.com/2013/02/05/science/a-look-at-bad-pharma-and-science-as-performance.html
http://www.nytimes.com/aponline/2013/02/19/us/ap-us-ri-nightclub-fire-glance.html
http://www.nytimes.com/aponline/2013/02/01/business/ap-us-kalobios-pharma-ipo.html
http://www.nytimes.com/reuters/2013/02/08/sports/cycling/08reuters-cycling-qatar-cavendish.html
http://www.nytimes.com/aponline/2013/02/04/us/politics/ap-us-fda-cancer-drug.html
http://www.nytimes.com/2013/02/08/movies/steven-soderberghs-caper-film-side-effects.html
http://www.nytimes.com/2013/02/08/movies/steven-soderberghs-caper-film-side-effects.html
http://www.nytimes.com/aponline/2013/01/29/business/ap-us-wall-street-summary-box.html
http://www.nytimes.com/2013/01/16/nyregion/ny-police-to-track-drugstore-robbers-via-decoy-bottles.html
http://www.nytimes.com/aponline/2013/01/27/business/ap-us-wall-street-week-ahead.html
http://www.nytimes.com/reuters/2013/01/23/business/23reuters-novartis.html
http://www.nytimes.com/aponline/2013/01/25/business/ap-us-wall-street-week-ahead.html
http://www.nytimes.com/2013/01/02/health/drug-makers-losing-a-bid-to-foil-generic-painkillers.html
http://www.nytimes.com/aponline/2012/12/31/us/ap-us-hgh-growing-use.html
http://www.nytimes.com/2013/01/15/business/roche-hires-dr-john-reed-to-lead-research-operations.html
http://www.nytimes.com/aponline/2013/01/10/us/politics/ap-us-sleeping-pills-fda-safety.html
http://www.nytimes.com/aponline/2013/01/10/us/ap-us-pharma-on-campus.html
http://www.nytimes.com/2013/01/11/nyregion/new-york-city-to-restrict-powerful-prescription-drugs-in-public-hospitals-emergency-rooms.html
http://www.nytimes.com/aponline/2012/12/21/us/ap-us-hgh-growing-use.html
http://www.nytimes.com/aponline/2012/12/31/business/ap-us-business-highlights-.html
http://www.nytimes.com/aponline/2012/12/21/us/ap-10-things-to-know-friday.html
http://www.nytimes.com/aponline/2012/12/21/business/ap-us-business-highlights.html
http://www.nytimes.com/reuters/2012/12/19/sports/cycling/19reuters-yearender-cycling.html
http://www.nytimes.com/reuters/2012/12/12/business/12reuters-markets-stocks-ftse-rejigurgent.html
http://www.nytimes.com/reuters/2012/12/10/business/10reuters-markets-stocks-ftse-rejig.html
http://www.nytimes.com/2012/12/04/business/generic-drug-makers-facing-squeeze-on-revenue.html
http://www.nytimes.com/reuters/2012/11/12/world/europe/12reuters-croatia-pharmaceuticals-bribery.html
http://www.nytimes.com/aponline/2012/11/14/business/ap-us-fiscal-cliff-health-care-summary-box.html
http://www.nytimes.com/reuters/2012/11/05/business/05reuters-abbott.html
http://krugman.blogs.nytimes.com/2012/11/14/the-austerity-bomb/
http://www.nytimes.com/reuters/2012/11/13/world/americas/13reuters-pharmaceuticals-fake-who.html
http://www.nytimes.com/reuters/2012/11/01/technology/01reuters-cancer-tech.html
http://www.nytimes.com/aponline/2012/10/15/us/ap-us-wall-street-close.html
http://www.nytimes.com/2012/10/28/magazine/will-we-be-better-off-in-2016.html
http://www.nytimes.com/reuters/2012/10/25/business/25reuters-astrazeneca-earnings.html
http://www.nytimes.com/2012/10/17/sports/cycling/levi-leipheimer-dropped-from-cycling-team.html
http://www.nytimes.com/aponline/2012/10/16/sports/ap-cyc-quick-step-leipheimer-fired.html
http://www.nytimes.com/aponline/2012/10/22/business/ap-us-business-highlights.html
http://www.nytimes.com/reuters/2012/10/15/business/15reuters-cinven.html
http://well.blogs.nytimes.com/2012/10/18/are-doctors-too-wary-of-drug-companies/
http://www.nytimes.com/aponline/2012/10/16/sports/olympics/ap-oly-ioc-armstrong.html
http://www.nytimes.com/reuters/2012/10/11/business/11reuters-glaxosmithkline-data.html
http://campaignstops.blogs.nytimes.com/2012/10/09/douthat-liberalisms-glass-jaw/
http://dealbook.nytimes.com/2012/10/04/with-banks-skittish-europes-private-equity-firms-look-elsewhere/
http://www.nytimes.com/reuters/2012/10/04/business/04reuters-biotech-belgium.html
http://www.nytimes.com/reuters/2012/09/16/business/16reuters-allianceboots-china-stake.html
http://www.nytimes.com/reuters/2012/09/11/business/11reuters-india-fdi.html
http://www.nytimes.com/2012/09/21/movies/doctored-a-defense-of-chiropractic-aid.html
http://www.nytimes.com/2012/09/26/business/mice-as-stand-ins-in-the-fight-against-disease.html
http://www.nytimes.com/2012/09/21/movies/doctored-a-defense-of-chiropractic-aid.html
http://www.nytimes.com/reuters/2012/09/16/sports/cycling/16reuters-cycling-world-team-timetrial.html
http://www.nytimes.com/reuters/2012/09/19/sports/cycling/19reuters-cycling-world-men-timetrial.html
http://www.nytimes.com/2012/09/20/health/washington-state-makes-it-harder-to-forgo-immunizations.html
http://www.nytimes.com/2012/09/17/business/media/accounts-and-people-of-note-in-the-advertising-industry.html
http://www.nytimes.com/reuters/2012/09/17/world/asia/17reuters-india-pharma-kickbacks.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/reuters/2012/09/08/sports/cycling/08reuters-cycling-britain-sky-cavendish.html
http://www.nytimes.com/reuters/2012/09/01/business/01reuters-bayer-greece-exit.html
http://www.nytimes.com/2012/09/03/opinion/my-asian-dad-and-mitt-romneys-muffin-tops.html
http://www.nytimes.com/2012/09/04/business/global/bribery-settlements-under-us-law-are-mostly-with-foreign-countries.html
http://www.nytimes.com/reuters/2012/08/20/business/20reuters-novartis-india.html
http://www.nytimes.com/reuters/2012/08/19/business/19reuters-novartis-india.html
http://www.nytimes.com/2012/09/04/business/global/bribery-settlements-under-us-law-are-mostly-with-foreign-countries.html
http://www.nytimes.com/reuters/2012/08/29/us/29reuters-heart-pharmaceuticals.html
http://www.nytimes.com/2012/09/03/opinion/my-asian-dad-and-mitt-romneys-muffin-tops.html
http://www.nytimes.com/reuters/2012/08/28/business/28reuters-astrazeneca-ceo.html
http://www.nytimes.com/reuters/2012/08/22/business/22reuters-india-novartis.html
http://www.nytimes.com/reuters/2012/08/18/sports/cycling/18reuters-cycling-vuelta-winner.html
http://www.nytimes.com/reuters/2012/08/22/business/22reuters-ireland-exports.html
http://www.nytimes.com/aponline/2012/08/06/us/ap-us-teva-pharma-sec-investigation.html
http://www.nytimes.com/2012/08/20/sports/cycling/usa-pro-challenge-cycling-race-makes-final-miles-count-the-most.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-teva-pharma-sec-investigation-summary-box.html
http://www.nytimes.com/reuters/2012/08/18/sports/cycling/18reuters-cycling-spain.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-k-v-pharma-bankruptcy-summary-box.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-k-v-pharma-bankruptcy.html
http://www.nytimes.com/2012/08/20/sports/cycling/usa-pro-challenge-cycling-race-makes-final-miles-count-the-most.html
http://www.nytimes.com/aponline/2012/08/16/business/ap-us-agilent-mover.html
http://www.nytimes.com/reuters/2012/08/15/business/15reuters-aspenpharmacare-gsk.html
http://tmagazine.blogs.nytimes.com/2012/08/14/glow-biz/
http://www.nytimes.com/reuters/2012/08/10/business/10reuters-icahn-forest-poisonpill.html
http://dealbook.nytimes.com/2012/08/08/kindler-former-pfizer-chief-joins-lux-capital/
http://query.nytimes.com/gst/fullpage.html?res=9C05E7DF1738F93AA3575BC0A9649D8B63
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-business-highlights.html
http://www.nytimes.com/reuters/2012/08/01/business/01reuters-forest-icahn-iss.html
http://www.nytimes.com/2012/07/26/business/doctors-petition-fda-for-painkiller-limits.html
http://www.nytimes.com/2012/07/26/business/doctors-petition-fda-for-painkiller-limits.html
http://opinionator.blogs.nytimes.com/2012/07/24/more-on-milk/
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/video/business/100000001643644/business-day-live-july-3-2012.html
http://www.nytimes.com/video/2012/07/03/business/100000001643644/business-day-live-july-3-2012.html
http://www.nytimes.com/2012/07/10/sports/cycling/10iht-tour10.html
http://dealbook.nytimes.com/2012/07/03/business-day-live-glaxo-to-pay-3-billion-in-fines/
http://www.nytimes.com/2012/07/10/sports/cycling/10iht-tour10.html
http://www.nytimes.com/2012/07/05/sports/cycling/05iht-bike05.html
http://www.nytimes.com/2012/07/03/sports/cycling/mark-cavendish-wins-tour-sprint-even-without-teammates-help.html
http://www.nytimes.com/2012/07/05/sports/cycling/no-respite-in-getting-tour-de-france-riders-to-finish.html
http://www.nytimes.com/2012/07/03/sports/cycling/mark-cavendish-wins-tour-sprint-even-without-teammates-help.html
http://www.nytimes.com/2012/07/05/sports/cycling/no-respite-in-getting-tour-de-france-riders-to-finish.html
http://www.nytimes.com/2012/07/05/sports/cycling/05iht-bike05.html
http://www.nytimes.com/reuters/2012/06/28/sports/cycling/28reuters-cycling-tour-leipheimer.html
http://www.nytimes.com/2012/06/30/sports/cycling/riders-to-watch-at-the-tour-de-france.html
http://www.nytimes.com/reuters/2012/06/28/sports/cycling/28reuters-cycling-tour-leipheimer.html
http://www.nytimes.com/2012/06/30/sports/cycling/riders-to-watch-at-the-tour-de-france.html
http://www.nytimes.com/reuters/2012/06/26/technology/26reuters-pharma-games.html
http://krugman.blogs.nytimes.com/2012/06/17/meanwhile-in-the-role-model/
http://www.nytimes.com/2012/06/19/health/study-tests-if-progesterone-can-save-lives-after-brain-injury.html
http://www.nytimes.com/2012/06/19/health/study-tests-if-progesterone-can-save-lives-after-brain-injury.html
http://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html
http://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html
http://www.nytimes.com/2012/06/01/business/a-new-class-of-cancer-drugs-may-be-less-toxic.html
http://www.nytimes.com/2012/06/01/business/a-new-class-of-cancer-drugs-may-be-less-toxic.html
http://www.nytimes.com/2012/05/09/health/senate-panel-to-examine-narcotic-drug-makers-financial-ties.html
http://www.nytimes.com/2012/05/09/health/senate-panel-to-examine-narcotic-drug-makers-financial-ties.html
http://dealbook.nytimes.com/2012/05/07/morning-take-out-478/
http://www.nytimes.com/2012/05/07/business/media/accounts-and-people-of-note-in-the-advertising-industry.html
http://www.nytimes.com/2012/05/07/business/media/accounts-and-people-of-note-in-the-advertising-industry.html
http://www.nytimes.com/2012/05/02/business/pfizer-profit-declines-19-after-loss-of-lipitor-patent.html
http://www.nytimes.com/2012/05/02/business/pfizer-profit-declines-19-after-loss-of-lipitor-patent.html
http://www.nytimes.com/2012/04/22/fashion/weddings/yiyang-wu-benjamin-cheng-weddings.html
http://www.nytimes.com/2012/04/22/fashion/weddings/yiyang-wu-benjamin-cheng-weddings.html
http://india.blogs.nytimes.com/2012/04/17/indian-companies-spend-overseas-for-growth/
http://www.nytimes.com/2012/04/12/business/drug-giant-is-fined-1-2-billion-in-arkansas.html
http://www.nytimes.com/2012/04/12/business/drug-giant-is-fined-1-2-billion-in-arkansas.html
http://query.nytimes.com/gst/fullpage.html?res=9801E7DD1231F931A25757C0A9649D8B63
http://dealbook.nytimes.com/2012/04/11/morning-take-out-460/
http://dealbook.nytimes.com/2012/04/11/takeda-of-japan-buys-url-pharma-for-800-million/
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2012/03/27/science/profiting-from-medicine.html
http://www.nytimes.com/2012/03/27/science/profiting-from-medicine.html
http://www.nytimes.com/2012/03/20/business/ex-adviser-pleads-guilty-in-insider-trading-case.html
http://www.nytimes.com/2012/03/20/science/a-drumbeat-on-profit-takers.html
http://www.nytimes.com/2012/03/20/science/a-drumbeat-on-profit-takers.html
http://www.nytimes.com/2012/03/20/business/ex-adviser-pleads-guilty-in-insider-trading-case.html
http://query.nytimes.com/gst/fullpage.html?res=9C07EFDF123AF93BA25750C0A9649D8B63
http://opinionator.blogs.nytimes.com/2012/03/17/the-danish-doctor-of-dread/
http://india.blogs.nytimes.com/2012/03/13/india-orders-bayer-to-license-a-patented-drug/
http://www.nytimes.com/2012/03/13/business/global/india-overrules-bayer-allowing-generic-drug.html
http://www.nytimes.com/2012/03/13/business/global/india-overrules-bayer-allowing-generic-drug.html
http://www.nytimes.com/2012/03/09/business/trial-shows-benefit-in-earlier-use-of-zytiga-for-prostate-cancer.html
http://www.nytimes.com/2012/03/09/business/trial-shows-benefit-in-earlier-use-of-zytiga-for-prostate-cancer.html
http://dealbook.nytimes.com/2012/03/02/greek-official-warns-debt-holdouts/
http://dealbook.nytimes.com/2012/03/02/morning-take-out-433/
http://www.nytimes.com/2012/02/22/health/policy/fda-approves-imports-amid-shortage-of-2-cancer-drugs.html
http://www.nytimes.com/2012/02/22/health/policy/fda-approves-imports-amid-shortage-of-2-cancer-drugs.html
http://www.nytimes.com/2012/02/08/theater/reviews/marin-hinkle-in-rx-by-kate-fodor-at-59e59-theaters.html
http://theater2.nytimes.com/2012/02/08/theater/reviews/marin-hinkle-in-rx-by-kate-fodor-at-59e59-theaters.html
http://www.nytimes.com/reuters/2012/01/13/business/business-us-healthcare-investors.html
http://www.nytimes.com/reuters/2012/01/13/business/business-us-novartis.html
http://www.nytimes.com/aponline/2012/01/12/us/AP-US-Powerful-Painkiller.html
http://www.nytimes.com/2012/01/09/nyregion/anxious-days-for-long-island-pharmacies.html
http://www.nytimes.com/2012/01/09/nyregion/anxious-days-for-long-island-pharmacies.html
http://www.nytimes.com/2012/01/05/business/media/mdc-partners-picks-up-rj-palmer.html
http://www.nytimes.com/2012/01/05/business/media/mdc-partners-picks-up-rj-palmer.html
http://dealbook.nytimes.com/2011/12/29/the-top-of-the-class-in-deal-making/
http://bucks.blogs.nytimes.com/2011/12/27/tuesday-reading-how-government-austerity-affects-health-care/
http://krugman.blogs.nytimes.com/2011/12/21/the-imf-on-ireland/
http://krugman.blogs.nytimes.com/2011/12/19/irish-competitiveness-wonkish/
http://www.nytimes.com/2011/12/18/magazine/reply-all-mitt-romney-bot.html
http://www.nytimes.com/2011/12/18/magazine/reply-all-mitt-romney-bot.html
http://www.nytimes.com/2011/12/12/business/media/accounts-and-people-of-note-in-the-advertising-industry.html
http://www.nytimes.com/2011/12/11/magazine/a-o-scott-screen-villains.html
http://www.nytimes.com/2011/12/11/magazine/a-o-scott-screen-villains.html
http://krugman.blogs.nytimes.com/2011/12/06/irish-pfizer-smiling/
http://prescriptions.blogs.nytimes.com/2011/11/21/a-step-forward-for-rna-interference/
http://www.nytimes.com/2011/11/04/business/glaxo-to-pay-3-billion-in-avandia-settlement.html
http://query.nytimes.com/gst/fullpage.html?res=9A04E6DA173CF937A35752C1A9679D8B63
http://www.nytimes.com/2011/11/04/business/glaxo-to-pay-3-billion-in-avandia-settlement.html
http://prescriptions.blogs.nytimes.com/2011/11/03/prostate-cancer-drug-shows-promise-in-study/
http://www.nytimes.com/2011/11/02/business/spurring-growth-on-bostons-waterfront.html
http://www.nytimes.com/2011/11/02/business/spurring-growth-on-bostons-waterfront.html
http://krugman.blogs.nytimes.com/2011/10/25/irish-reality-check/
http://dealbook.nytimes.com/2011/10/21/for-british-ex-bankers-life-beyond-the-bailouts/
http://www.nytimes.com/2011/10/19/business/opportunities-abound-even-for-the-risk-averse.html
http://www.nytimes.com/2011/10/19/business/opportunities-abound-even-for-the-risk-averse.html
http://www.nytimes.com/2011/10/16/opinion/sunday/how-medicare-fails-the-elderly.html
http://www.nytimes.com/2011/10/16/business/in-the-breast-cancer-fight-the-pinking-of-america.html
http://query.nytimes.com/gst/fullpage.html?res=9D02E3DE1E38F935A25753C1A9679D8B63
http://www.nytimes.com/2011/10/16/opinion/sunday/how-medicare-fails-the-elderly.html
http://www.nytimes.com/2011/10/09/opinion/sunday/brain-injury-and-building-a-new-life-afterwards.html
http://www.nytimes.com/2011/10/09/opinion/sunday/brain-injury-and-building-a-new-life-afterwards.html
http://krugman.blogs.nytimes.com/2011/09/30/ireland-triumphs/
http://www.nytimes.com/2011/09/21/business/media/to-address-a-reshaped-market-grey-adds-a-unit.html
http://www.nytimes.com/2011/09/21/business/media/to-address-a-reshaped-market-grey-adds-a-unit.html
http://india.blogs.nytimes.com/2011/09/20/the-battle-over-generic-drugs-continues/
http://6thfloor.blogs.nytimes.com/2011/09/19/three-favorite-novels-by-le-carre/
http://www.nytimes.com/2011/09/16/business/media/uncertainty-on-wall-street-big-deals-on-madison-avenue.html
http://www.nytimes.com/2011/09/16/business/media/uncertainty-on-wall-street-big-deals-on-madison-avenue.html
http://www.nytimes.com/2011/09/06/business/doctors-discover-the-benefits-of-business-school.html
http://www.nytimes.com/2011/09/06/business/doctors-discover-the-benefits-of-business-school.html
http://dealbook.nytimes.com/2011/09/01/a-busy-day-for-insider-trading-cases/
http://www.nytimes.com/2011/08/27/opinion/empowering-medicare.html
http://www.nytimes.com/2011/08/27/opinion/empowering-medicare.html
http://www.legacy.com/Link.asp?I=LS000153259749
http://query.nytimes.com/gst/fullpage.html?res=9505EFDF113AF930A1575BC0A9679D8B63
http://www.nytimes.com/2011/08/20/business/lawyer-sentenced-in-insider-trading-case.html
http://www.nytimes.com/2011/08/20/business/lawyer-sentenced-in-insider-trading-case.html
http://dealbook.nytimes.com/2011/08/19/lawyer-tied-to-galleon-case-gets-3-years-in-prison/
http://dotearth.blogs.nytimes.com/2011/08/11/planet-of-the-hominids/
http://www.nytimes.com/2011/08/05/movies/rise-of-the-planet-of-the-apes-stars-james-franco-review.html
http://www.nytimes.com/2011/08/05/movies/rise-of-the-planet-of-the-apes-stars-james-franco-review.html
http://www.nytimes.com/2011/07/31/fashion/weddings/anika-leerssen-chad-marriott-weddings.html
http://www.nytimes.com/2011/07/31/fashion/weddings/anika-leerssen-chad-marriott-weddings.html
http://query.nytimes.com/gst/fullpage.html?res=9501E4D7143EF933A05754C0A9679D8B63
http://prescriptions.blogs.nytimes.com/2011/07/29/merck-plans-more-job-cuts/
http://opinionator.blogs.nytimes.com/2011/07/26/a-trade-barrier-to-defeating-aids/
http://dealbook.nytimes.com/2011/07/21/express-scripts-to-buy-medco-for-29-billion/
http://dealbook.nytimes.com/2011/07/20/morning-take-out-289/
http://query.nytimes.com/gst/fullpage.html?res=9C0CE0DA143CF93AA25754C0A9679D8B63
http://prescriptions.blogs.nytimes.com/2011/07/18/antismoking-vaccine-fails-in-late-trial/
http://www.nytimes.com/2011/07/18/health/18diabetes.html
http://www.nytimes.com/2011/07/18/health/18diabetes.html
http://www.nytimes.com/2011/07/13/sports/cycling/german-sprinter-andre-greipel-wins-stage-10-of-tour-de-france.html
http://www.nytimes.com/2011/07/13/sports/cycling/german-sprinter-andre-greipel-wins-stage-10-of-tour-de-france.html
http://dealbook.nytimes.com/2011/07/11/lonza-to-buy-arch-chemicals-for-1-2-billion/
http://www.nytimes.com/2011/07/10/opinion/sunday/10antidepressants.html
http://www.nytimes.com/2011/07/10/opinion/sunday/10antidepressants.html
http://www.nytimes.com/2011/07/08/sports/cycling/08iht-cycle08.html
http://www.nytimes.com/2011/07/08/arts/television/torchwood-returns-for-season-4-on-starz-review.html
http://www.nytimes.com/2011/07/08/arts/television/torchwood-returns-for-season-4-on-starz-review.html
http://www.nytimes.com/2011/07/03/fashion/weddings/lindsay-ross-garrett-ricciardi-weddings.html
http://www.nytimes.com/2011/07/03/fashion/weddings/lindsay-ross-garrett-ricciardi-weddings.html
http://www.nytimes.com/2011/06/16/health/16oxy.html
http://www.nytimes.com/2011/06/16/health/16oxy.html
http://query.nytimes.com/gst/fullpage.html?res=9C0CE2DF103FF937A25755C0A9679D8B63
http://dealbook.nytimes.com/2011/06/13/zvi-goffer-found-guilty-in-insider-trading-case/
http://prescriptions.blogs.nytimes.com/2011/06/09/ucb-pays-34-million-pleads-guilty-in-epilepsy-drug-fraud-case/
http://dealbook.nytimes.com/2011/05/24/nestle-to-buy-diagnostics-firm/
http://query.nytimes.com/gst/fullpage.html?res=9C03E0DD133BF93AA25756C0A9679D8B63
http://dealbook.nytimes.com/2011/05/18/ex-diamondback-manager-pleaded-guilty-to-insider-trading/
http://www.nytimes.com/2011/05/16/business/16insider.html
http://www.nytimes.com/2011/05/16/business/16insider.html
http://query.nytimes.com/gst/fullpage.html?res=9C05E3D91338F930A25756C0A9679D8B63
http://dealbook.nytimes.com/2011/05/12/takeda-in-talks-to-buy-nycomed-for-up-to-14-billion/
http://www.nytimes.com/2011/05/07/business/global/07austerity.html
http://www.nytimes.com/2011/05/07/business/global/07austerity.html
http://opinionator.blogs.nytimes.com/2011/05/05/fostering-a-team-approach-to-drug-cures/
http://opinionator.blogs.nytimes.com/2011/05/02/helping-new-drugs-out-of-academias-valley-of-death/
http://dealbook.nytimes.com/2011/05/02/morning-take-out-234/
http://www.nytimes.com/2011/05/01/business/01stream.html
http://www.nytimes.com/2011/05/01/business/01stream.html
http://www.nytimes.com/2011/04/28/opinion/l28drugs.html
http://www.nytimes.com/2011/04/28/opinion/l28drugs.html
http://query.nytimes.com/gst/fullpage.html?res=9E00EEDC1730F934A15757C0A9679D8B63
http://dealbook.nytimes.com/2011/04/26/trader-who-worked-with-galleon-pleads-guilty/
http://www.nytimes.com/2011/04/20/health/20painkiller.html
http://www.nytimes.com/2011/04/20/health/20painkiller.html
http://www.nytimes.com/2011/04/14/us/14lethal.html
http://www.nytimes.com/2011/04/14/us/14lethal.html
http://www.nytimes.com/2011/03/31/world/europe/31iht-letter31.html
http://www.nytimes.com/2011/03/18/world/europe/18russia.html
http://www.nytimes.com/2011/03/18/world/europe/18russia.html
http://www.nytimes.com/2011/03/17/us/17drugs.html
http://www.nytimes.com/2011/03/17/us/17drugs.html
http://www.nytimes.com/2011/03/16/us/16lethal.html
http://www.nytimes.com/2011/03/16/us/16lethal.html
http://www.nytimes.com/2011/03/07/business/07drug.html
http://www.nytimes.com/2011/03/07/business/07drug.html
http://www.nytimes.com/2011/03/01/business/global/01drug.html
http://www.nytimes.com/2011/03/01/business/global/01drug.html
http://query.nytimes.com/gst/fullpage.html?res=9F00E0DD173CF930A15751C0A9679D8B63
http://www.nytimes.com/2011/02/07/us/07pharmacies.html
http://www.nytimes.com/2011/02/07/us/07pharmacies.html
http://www.nytimes.com/2011/02/06/magazine/06FOB-Medium-t.html
http://www.nytimes.com/2011/02/06/magazine/06FOB-Medium-t.html
http://www.nytimes.com/2011/01/28/opinion/28fri3.html
http://www.nytimes.com/2011/01/28/opinion/28fri3.html
http://query.nytimes.com/gst/fullpage.html?res=9804E5DC1731F934A15752C0A9679D8B63
http://dealbook.nytimes.com/2011/01/26/another-guilty-plea-in-galleon-case/
http://www.nytimes.com/2011/01/26/us/26lethal.html
http://www.nytimes.com/2011/01/26/us/26lethal.html
http://prescriptions.blogs.nytimes.com/2011/01/11/lilly-enters-diabetes-alliance-with-b-i/
http://www.nytimes.com/2010/12/16/business/16purdue.html
http://www.nytimes.com/2010/12/13/world/asia/13iht-educLede13.html
http://www.nytimes.com/2010/12/06/business/06drug.html
http://www.nytimes.com/2010/12/05/world/africa/05meningitis.html
http://www.nytimes.com/2010/12/05/books/review/Crime-t.html
http://www.nytimes.com/2010/11/08/business/media/08adnewsletter3.html
http://www.nytimes.com/2010/11/02/science/02scibks.html
http://www.nytimes.com/2010/11/01/business/media/01adnewsletter3.html
http://prescriptions.blogs.nytimes.com/2010/10/27/recommended-reading-bad-science/
http://www.nytimes.com/2010/10/27/business/27drug.html
http://dealbook.nytimes.com/2010/10/14/blackstone-and-bain-plan-bids-for-pfizer-capsule-unit/
http://dealbook.nytimes.com/2010/10/11/chinese-pharma-set-to-raise-741-million/
http://www.nytimes.com/2010/10/11/business/media/11adnewsletter3.html
http://www.nytimes.com/2010/10/03/business/03psych.html
http://dealbook.nytimes.com/2010/09/28/endo-pharma-to-buy-qualitest-for-1-2-billion/
http://www.nytimes.com/2010/09/28/business/global/28nestle.html
http://www.nytimes.com/2010/09/28/health/28zuger.html
http://dealbook.nytimes.com/2010/09/27/nestle-seeks-to-expand-in-healthcare-nutrition/
http://www.nytimes.com/2010/09/23/business/23novartis.html
http://www.nytimes.com/2010/09/21/health/21placebo.html
http://www.nytimes.com/2010/09/21/health/21bbox.html
http://www.nytimes.com/2010/09/19/realestate/19wczo.html
http://www.nytimes.com/2010/09/14/health/research/14bowel.html
http://dealbook.nytimes.com/2010/09/10/shanghai-pharma-plans-1-2-billion-hong-kong-i-p-o/
http://www.nytimes.com/2010/09/07/business/media/07adnewsletter3.html
http://www.nytimes.com/2010/08/31/health/research/31muscleside.html
http://www.nytimes.com/2010/08/29/magazine/29preschool-t.html
http://prescriptions.blogs.nytimes.com/2010/08/27/heart-beats-in-stockholm/
http://thecaucus.blogs.nytimes.com/2010/08/19/obamas-struggles-answers-from-matt-bai-part-iii/
http://www.nytimes.com/2010/08/14/health/policy/14pill.html
http://www.nytimes.com/2010/08/01/books/review/Verghese-t.html
http://www.nytimes.com/2010/07/29/business/29pain.html
http://prescriptions.blogs.nytimes.com/2010/07/19/this-weeks-health-industry-news-2/
http://query.nytimes.com/gst/fullpage.html?res=9801E1DA1F31F932A25754C0A9669D8B63
http://www.nytimes.com/2010/07/07/business/global/07indiadrug.html
http://www.nytimes.com/2010/06/20/books/review/Scarf-t.html
http://www.nytimes.com/2010/06/18/health/policy/18pill.html
http://dealbook.nytimes.com/2010/06/09/caseys-general-stores-loves-iowa/
http://dealbook.nytimes.com/2010/06/03/astellas-extends-tender-offer-for-osi/
http://www.nytimes.com/2010/05/30/business/30stream.html
http://dealbook.nytimes.com/2010/05/24/behind-the-trends-in-an-m-a-uptick/
http://query.nytimes.com/gst/fullpage.html?res=9C07E7DD1639F930A15756C0A9669D8B63
http://www.nytimes.com/2010/05/17/business/global/17osi.html
http://dealbook.nytimes.com/2010/05/16/osi-to-sell-itself-to-astellas-for-4-billion/
http://www.nytimes.com/2010/05/09/business/09teva.html
http://www.nytimes.com/2010/04/27/business/global/27deal.html
http://dealbook.nytimes.com/2010/04/26/charles-river-buys-chinese-drug-research-firm/
http://www.nytimes.com/2010/04/21/business/21device.html
http://www.nytimes.com/2010/04/13/business/13docpay.html
http://www.nytimes.com/2010/04/06/business/06oxy.html
http://dealbook.nytimes.com/2010/04/05/gazing-into-the-crystal-ball-for-april/
http://mediadecoder.blogs.nytimes.com/2010/04/05/chipotle-bites-the-hand-it-used-to-feed/
http://dealbook.nytimes.com/2010/04/01/the-pace-of-deal-making-picks-up/
http://www.nytimes.com/2010/04/01/business/01sackler.html
http://www.nytimes.com/2010/04/01/business/01DEALS.html
http://query.nytimes.com/gst/fullpage.html?res=9B02E4DE1439F932A35757C0A9669D8B63
http://dealbook.nytimes.com/2010/03/24/shades-of-wall-street-in-insider-trading-arrests/
http://dealbook.nytimes.com/2010/03/22/the-price-of-goofs-in-deal-making/
http://roomfordebate.blogs.nytimes.com/2010/03/21/a-historic-moment-for-health-care/
http://dealbook.nytimes.com/2010/03/21/does-icahn-still-make-them-tremble/
http://www.nytimes.com/2010/03/21/business/21icahn.html
http://www.nytimes.com/2010/03/15/health/policy/15health.html
http://www.nytimes.com/2010/03/14/magazine/14emanuel-t.html
http://green.blogs.nytimes.com/2010/03/09/scientists-develop-highly-recyclable-plastic/
http://dealbook.nytimes.com/2010/03/05/another-deal-grab-bag-astellas-cf-airgas-and-more/
http://dealbook.nytimes.com/2010/03/05/putting-high-takeover-premiums-in-perspective/
http://www.nytimes.com/2010/03/05/business/05views.html
http://dealbook.nytimes.com/2010/03/03/archimedes-gets-98-million-injection/
http://dealbook.nytimes.com/2010/03/02/pfizer-said-to-set-sights-on-german-drug-maker/
http://dealbook.nytimes.com/2010/03/02/will-rival-bidders-join-the-fray-for-osi/
http://www.nytimes.com/2010/03/02/business/02drug.html
http://dealbook.nytimes.com/2010/03/01/astellas-bids-3-5-billion-for-osi/
http://dealbook.nytimes.com/2010/02/28/germanys-merck-to-buy-millipore-for-7-2-billion/
http://query.nytimes.com/gst/fullpage.html?res=9507E7D8103AF934A25751C0A9669D8B63
http://www.legacy.com/Link.asp?I=LS000139787730
http://dealbook.nytimes.com/2010/02/16/quintiles-expands-stake-in-big-pharma/
http://www.nytimes.com/2010/02/14/books/review/EdChoice-t.html
http://www.nytimes.com/2010/02/09/health/09prof.html
http://www.nytimes.com/2010/01/29/opinion/l29obama.html
http://dealbook.nytimes.com/2010/01/27/kurland-pleads-guilty-in-galleon-insider-case/
http://dealbook.nytimes.com/2010/01/27/kurland-will-not-cooperate-in-galleon-case/
http://www.nytimes.com/2010/01/27/business/27insider.html
http://www.nytimes.com/2010/01/25/opinion/25douthat.html
http://www.nytimes.com/2010/01/22/business/22insider.html
http://dealbook.nytimes.com/2010/01/04/merz-to-buy-bioform-medical-for-253-million/
http://query.nytimes.com/gst/fullpage.html?res=9C0CE3D6143BF933A05751C1A96F9C8B63
http://query.nytimes.com/gst/fullpage.html?res=9C02EFD61339F933A05751C1A96F9C8B63
http://www.nytimes.com/2009/12/29/realestate/30office.html
http://opinionator.blogs.nytimes.com/2009/12/23/profiles-in-cowardice/
http://www.nytimes.com/2009/12/13/business/13drug.html
http://www.nytimes.com/2009/12/13/business/13stream.html
http://www.nytimes.com/2009/12/13/business/13stream.html
http://query.nytimes.com/gst/fullpage.html?res=9C06E2DD1739F930A25751C1A96F9C8B63
http://www.nytimes.com/2009/12/11/business/11insider.html
http://www.nytimes.com/2009/12/11/business/11insider.html
http://dealbook.nytimes.com/2009/12/10/ex-ropes-gray-lawyer-pleads-guilty-in-galleon-case/
http://dealbook.nytimes.com/2009/12/08/apax-buys-pharma-support-firm-marken/
http://www.nytimes.com/2009/11/29/books/review/Sanghavi-t.html
http://query.nytimes.com/gst/fullpage.html?res=9500E5DA113CF93AA15752C1A96F9C8B63
http://www.nytimes.com/2009/11/21/opinion/l21drug.html
http://query.nytimes.com/gst/fullpage.html?res=9A07E0DB1531F932A15752C1A96F9C8B63
http://economix.blogs.nytimes.com/2009/11/18/health-care-reform-and-mckinseys-client-x/
http://economix.blogs.nytimes.com/2009/11/13/afghanistans-lessons-for-health-care-reform/
http://www.nytimes.com/2009/11/06/business/06network.html
http://dealbook.nytimes.com/2009/11/05/more-individuals-to-be-charged-with-insider-trading/
http://www.nytimes.com/2009/11/05/books/05book.html
http://www.nytimes.com/2009/10/22/health/22nami.html
http://www.nytimes.com/2009/10/21/business/21biotech.html
http://ethicist.blogs.nytimes.com/2009/10/20/should-photos-come-with-warning-labels/
http://www.nytimes.com/2009/10/18/realestate/18njzo.html
http://dealbook.nytimes.com/2009/10/13/onyx-pharma-swallows-proteolix/
http://www.nytimes.com/2009/10/07/business/global/07eurodrugs.html
http://www.nytimes.com/2009/09/20/business/20stream.html
http://schott.blogs.nytimes.com/2009/09/15/beagle-smoking-issues/
http://www.nytimes.com/2009/09/04/business/global/04drug.html
http://dealbook.nytimes.com/2009/09/03/drug-maker-dainippon-to-buy-sepracor-for-26-billion/
http://dealbook.nytimes.com/2009/08/21/adamas-completes-40-million-round/
http://roomfordebate.blogs.nytimes.com/2009/08/04/should-prescription-drug-ads-be-reined-in/
http://www.nytimes.com/2009/08/02/magazine/02fob-consumed-t.html
http://www.nytimes.com/2009/07/28/us/politics/28dodd.html
http://krugman.blogs.nytimes.com/2009/07/16/the-ama-as-good-guys/
http://dealbook.nytimes.com/2009/07/08/amcor-said-to-near-deal-for-some-of-rios-packaging-assets/
http://www.legacy.com/Link.asp?I=LS000128846685
http://query.nytimes.com/gst/fullpage.html?res=9401E1DD143AF937A15755C0A96F9C8B63
http://dealbook.nytimes.com/2009/06/17/uk-accuses-lawyers-at-us-firm-of-insider-trades/
http://www.nytimes.com/2009/06/17/business/global/17insider.html
http://dealbook.nytimes.com/2009/06/15/pfizer-looks-to-raise-presence-in-emerging-markets/
http://www.nytimes.com/2009/06/14/us/politics/14cong.html
http://www.nytimes.com/2009/06/14/fashion/weddings/14WHITFIELD.html
http://opinionator.blogs.nytimes.com/2009/06/11/health-care-reform-playoff-edition/
http://dealbook.nytimes.com/2009/05/20/novartis-pays-12-billion-for-cancer-drug-unit/
http://dealbook.nytimes.com/2009/05/18/takeda-swallos-idm-pharma-for-around-70-million/
http://www.nytimes.com/2009/05/17/nyregion/new-jersey/17pharmanj.html
http://opinionator.blogs.nytimes.com/2009/05/15/morning-skim-the-pelosi-sideshow/
http://query.nytimes.com/gst/fullpage.html?res=9C07E5DF143FF930A25756C0A96F9C8B63
http://opinionator.blogs.nytimes.com/2009/05/11/has-obama-found-a-pulse-on-health-care/
http://dealbook.nytimes.com/2009/05/06/safe-and-sound-at-13-million-a-year/
http://www.nytimes.com/2009/04/30/business/30wyeth.html
http://dealbook.nytimes.com/2009/03/30/looking-at-the-short-list-of-pending-deals/
http://dealbook.nytimes.com/2009/03/16/astellas-to-end-hostile-bid-for-cv-therapeutics/
http://dealbook.nytimes.com/2009/03/13/analysts-mixed-on-sweetened-astellas-bid-for-cv-therapeutics/
http://www.nytimes.com/2009/03/13/business/13biotech.html
http://dealbook.nytimes.com/2009/03/10/new-jersey-towns-worry-about-mergers-consequences/
http://www.nytimes.com/ref/health/healthguide/esn-kidney-disease-trials.html
http://dealbook.nytimes.com/2009/02/27/astellas-commences-tender-offer-in-cv-bid/
http://dealbook.nytimes.com/2009/02/24/astellas-still-wants-cv-therapeutics/
http://dealbook.nytimes.com/2009/02/19/glaxo-leads-23-million-round-for-genocea/
http://www.nytimes.com/2009/02/10/health/policy/10fda.html
http://www.nytimes.com/2009/02/04/business/04drug.html
http://dealbook.nytimes.com/2009/02/02/policy-group-questions-loans-for-pfizer-deal/
http://dealbook.nytimes.com/2009/01/27/astellas-makes-hostile-bid-for-cv-therapeutics/
http://dealbook.nytimes.com/2009/01/27/wyeth-deal-may-slow-pfizer-biotech-acquisitions/
http://dealbook.nytimes.com/2009/01/27/for-pfizer-a-big-deal-and-a-test/
http://www.nytimes.com/2009/01/27/business/27chief.html
http://www.nytimes.com/2009/01/27/business/27biotech.html
http://www.nytimes.com/2009/01/25/books/review/Grigoriadis-t.html
http://www.nytimes.com/2009/01/24/business/24pharma.html
http://www.nytimes.com/ref/health/healthguide/esn-mono-ess.html
http://query.nytimes.com/gst/fullpage.html?res=9E03E3DA113AF937A25752C0A96F9C8B63
http://www.nytimes.com/2009/01/11/business/mutfund/11topp.html
http://www.nytimes.com/2009/01/09/business/09views.html
http://www.nytimes.com/2009/01/04/opinion/lweb04drug.html
http://query.nytimes.com/gst/fullpage.html?res=9A06E7D61331F934A15751C1A96E9C8B63
http://www.nytimes.com/2008/11/25/health/research/25trials.html
http://www.nytimes.com/2008/11/10/business/media/10adnewsletter3.html
http://dealbook.nytimes.com/2008/10/29/financial-turmoil-threatens-biotechs-cash/
http://www.nytimes.com/2008/10/29/business/29biotech.html
http://dealbook.nytimes.com/2008/10/10/doubts-grow-over-lillys-imclone-deal/
http://www.nytimes.com/2008/10/09/arts/television/09test.html
http://dealbook.nytimes.com/2008/09/02/japanese-drug-maker-swallows-us-rival/
http://www.nytimes.com/2008/09/02/business/worldbusiness/02fashion.html
http://www.nytimes.com/2008/09/01/business/worldbusiness/02drug.html
http://query.nytimes.com/gst/fullpage.html?res=9400EFDB1230F93BA1575BC0A96E9C8B63
http://tierneylab.blogs.nytimes.com/2008/08/27/the-doped-games-first-winner/
http://www.nytimes.com/2008/08/20/health/policy/20vaccine.html
http://www.nytimes.com/ref/health/healthguide/esn-contraception-trials.html
http://www.nytimes.com/2008/07/22/business/worldbusiness/22roche.html